A2A S.p.A. (LON:0N54)
2.726
+0.017 (0.62%)
At close: Nov 6, 2025
A2A S.p.A. Revenue
A2A S.p.A. had revenue of 2.82B EUR in the quarter ending June 30, 2025, with 10.15% growth. This brings the company's revenue in the last twelve months to 13.44B, up 6.12% year-over-year. In the year 2024, A2A S.p.A. had annual revenue of 12.64B, down -13.64%.
Revenue (ttm)
13.44B EUR
Revenue Growth
+6.12%
P/S Ratio
0.64
Revenue / Employee
909.39K EUR
Employees
14,777
Market Cap
7.33B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.64B | -2.00B | -13.64% |
| Dec 31, 2023 | 14.63B | -8.42B | -36.53% |
| Dec 31, 2022 | 23.05B | 11.66B | 102.41% |
| Dec 31, 2021 | 11.39B | 4.70B | 70.37% |
| Dec 31, 2020 | 6.69B | -467.00M | -6.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |